-
Signature
-
/s/ Joseph Theis, attorney-in-fact
-
Issuer symbol
-
HUBS
-
Transactions as of
-
19 Aug 2025
-
Net transactions value
-
-$1,997,701
-
Form type
-
4
-
Filing time
-
21 Aug 2025, 16:10:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Halligan Brian |
Director |
C/O HUBSPOT, INC., 2 CANAL PARK, CAMBRIDGE |
/s/ Joseph Theis, attorney-in-fact |
21 Aug 2025 |
0001603527 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HUBS |
Common Stock |
Options Exercise |
$1,305,246 |
+7,136 |
+1.4% |
$182.91 |
529,571 |
19 Aug 2025 |
Direct |
F1 |
| transaction |
HUBS |
Common Stock |
Options Exercise |
$520,693 |
+1,364 |
+0.26% |
$381.74 |
530,935 |
19 Aug 2025 |
Direct |
F1 |
| transaction |
HUBS |
Common Stock |
Sale |
$3,823,640 |
-8,500 |
-1.6% |
$449.84 |
522,435 |
19 Aug 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
HUBS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-7,136 |
-100% |
$0.000000 |
0 |
19 Aug 2025 |
Common Stock |
7,136 |
$182.91 |
Direct |
F1, F2 |
| transaction |
HUBS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-1,364 |
-31% |
$0.000000 |
3,095 |
19 Aug 2025 |
Common Stock |
1,364 |
$381.74 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: